Analyst Ratings for Relay Therapeutics (RLAY)
RLAY Rating Summary
RLAY Price Target Summary
- Highest: $31.00 (Goldman Sachs)
- Lowest: $18.00 (Oppenheimer)
- Average: $25.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$25.50 (+37.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/16/2026 | Canaccord | John Newman | New Coverage | Buy (N/A) |
29.00 (N/A) |
19.51 (18.49) |
-5.23% | Details |
| 7/8/2026 | JPMorgan » Updated 8/14/2026 |
Priyanka Grover | New Coverage | Overweight (N/A) |
31.00 (28.00) |
18.90 (18.49) |
-2.17% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
